Michel Mouren

428 total citations
16 papers, 276 citations indexed

About

Michel Mouren is a scholar working on Reproductive Medicine, Analytical Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michel Mouren has authored 16 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Reproductive Medicine, 4 papers in Analytical Chemistry and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michel Mouren's work include Analytical Methods in Pharmaceuticals (4 papers), Pharmaceutical Economics and Policy (3 papers) and Hypothalamic control of reproductive hormones (2 papers). Michel Mouren is often cited by papers focused on Analytical Methods in Pharmaceuticals (4 papers), Pharmaceutical Economics and Policy (3 papers) and Hypothalamic control of reproductive hormones (2 papers). Michel Mouren collaborates with scholars based in France, Sweden and Canada. Michel Mouren's co-authors include Simone Jouquey, F. Delevallée, O. LE MARTRET, R. Deraedt, B. Lenfant, Patrice Jaillon, Christian Funck‐Brentano, Jean‐Louis Démolis, Tom Bryce and P Röbel and has published in prestigious journals such as Journal of Medicinal Chemistry, Human Reproduction and Fertility and Sterility.

In The Last Decade

Michel Mouren

16 papers receiving 254 citations

Peers

Michel Mouren

OC

CCM

RM

IMMUN

MB

Gerhard Boost United States

Darshana Patel India

P. De Schepper Belgium

Å Hanngren Sweden

Saul L. Cohen Canada

Jennifer M. Malinowski United States

Su-Er W. Huskey United States

Veronika Rozehnal Germany

F. Marfil Switzerland

Dae Won Sohn South Korea

Gerhard Boost United States

Michel Mouren

12 ×0.1

OC

14 ×0.2

CCM

45 ×1.0

RM

53 ×1.4

IMMUN

26 ×0.7

MB

Citations per year, relative to Michel Mouren Michel Mouren (= 1×) peers Gerhard Boost

Countries citing papers authored by Michel Mouren

Since Specialization

Citations

This map shows the geographic impact of Michel Mouren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Mouren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Mouren more than expected).

Fields of papers citing papers by Michel Mouren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Mouren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Mouren. The network helps show where Michel Mouren may publish in the future.

Co-authorship network of co-authors of Michel Mouren

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Mouren. A scholar is included among the top collaborators of Michel Mouren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Mouren. Michel Mouren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Danielson, Bo G., Serge Quérin, Pierre Larochelle, et al.. (1994). Pharmacokinetics and Pharmacodynamics of Trandolapril After Repeated Administration of 2 mg to Patients with Chronic Renal Failure and Healthy Control Subjects. Journal of Cardiovascular Pharmacology. 23. S50–59. 15 indexed citations

2.

Arner, Peter, Alan Wade, Peter Engfeldt, et al.. (1994). Pharmacokinetics and Pharmacodynamics of Trandolapril After Repeated Administration of 2 mg to Young and Elderly Patients with Mild-to-Moderate Hypertension. Journal of Cardiovascular Pharmacology. 23. S44–49. 10 indexed citations

3.

Arner, Peter, Peter Engfeldt, Michel Mouren, et al.. (1994). Pharmacokinetics and Pharmacodynamics of Trandolapril After Repeated Administration of 2 mg to Young and Elderly Patients with Mild-to-Moderate Hypertension. Journal of Cardiovascular Pharmacology. 23. S44–49. 20 indexed citations

4.

Lenfant, B., et al.. (1994). Trandolapril: pharmacokinetics of single oral doses in healthy male volunteers.. PubMed. 23 Suppl 4. S38–43. 17 indexed citations

5.

Danielson, Bo G., Serge Quérin, Pierre Larochelle, et al.. (1994). Pharmacokinetics and Pharmacodynamics of Trandolapril After Repeated Administration of 2 mg to Patients with Chronic Renal Failure and Healthy Control Subjects. Journal of Cardiovascular Pharmacology. 23. S50–59. 7 indexed citations

6.

Lenfant, B., et al.. (1994). Trandolapril. Journal of Cardiovascular Pharmacology. 23. S38–43. 4 indexed citations

7.

Lenfant, B., et al.. (1994). Trandolapril. Journal of Cardiovascular Pharmacology. 23. S38–43. 3 indexed citations

8.

Démolis, Jean‐Louis, et al.. (1993). Pharmacokinetics and Platelet Antiaggregating Effects of Beraprost, an Oral Stable Prostacyclin Analogue, in Healthy Volunteers. Journal of Cardiovascular Pharmacology. 22(5). 711–716. 47 indexed citations

9.

Germain, Guy, T.M. Mignot, P. Bischof, Michel Mouren, & L. Cédard. (1989). Plasma levels of SP1-like immunoreactive material (SP1) and progesterone throughout pregnancy and following RU 486-induced early abortion in the cynomolgus monkey (Macaca fascicularis). Human Reproduction. 4(8). 975–980. 3 indexed citations

10.

MARTRET, O. LE, et al.. (1988). 4-Hydroxy-3-quinolinecarboxamides with antiarthritic and analgesic activities. Journal of Medicinal Chemistry. 31(7). 1453–1462. 90 indexed citations

11.

Pendyala, Lakshmi, Creaven Pj, Robert P. Huben, et al.. (1987). Clinical pharmacokinetics of a new antiandrogen Anandron (RU 23908).. PubMed. 243A. 351–63. 5 indexed citations

12.

Mouren, Michel, et al.. (1987). Control of birth in rats by RU 486, an antiprogesterone compound. Reproduction. 79(1). 1–8. 12 indexed citations

13.

Gautray, J.P., et al.. (1981). Clinical Investigation of the Menstrual Cycle. III. Clinical, Endometrial, and Endocrine Aspects of Luteal Defect. Fertility and Sterility. 35(3). 296–303. 33 indexed citations

14.

Gautray, J.P., et al.. (1981). Clinical Investigation of the Menstrual Cycle. III. Clinical, Endometrial, and Endocrine Aspects of Luteal Defect. Obstetrical & Gynecological Survey. 36(8). 445–446. 1 indexed citations

15.

Raynaud, Jean‐Pierre, et al.. (1980). Inhibition of Progesterone Secretion During the Luteal Phase by Two Luteinizing Hormone-Releasing Hormone Agonists in Macaca fascicularis. Fertility and Sterility. 34(6). 593–598. 8 indexed citations

16.

Bonne, C., Michel Mouren, M.M. Bouton, D. Philibert, & Jean‐Philippe Raynaud. (1977). Radio-receptor-assay of plasma steroids. Journal of Steroid Biochemistry. 8(12). xvi–xvi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact